• 1
    Collins AJ, Couser WG, Dirks JH, et al. World Kidney Day: an idea whose time has come. Am J Kidney Dis 2006; 47: 375377.
  • 2
    Shah SV, Feehally J. The Third World Kidney Day: looking back and thinking forward. Am J Kidney Dis 2008; 51: 349352.
  • 3
    Shimamura T, Morrison AB. A progressive glomerulosclerosis occurring in partial five-sixths nephrectomized rats. Am J Pathol 1975; 79: 95106.
  • 4
    Hostetter TH, Olson JL, Rennke HG, et al. Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Am J Physiol 1981; 241: F85F93.
  • 5
    Kliem V, Johnson RJ, Alpers CE, et al. Mechanisms involved in the pathogenesis of tubulointerstitial fibrosis in 5/6-nephrectomized rats. Kidney Int 1996; 49: 666678.
  • 6
    Remuzzi G, Bertani T. Pathophysiology of progressive nephropathies. N Engl J Med 1998; 339: 14481456.
  • 7
    Eddy AA. Molecular basis of renal fibrosis. Pediatr Nephrol 2000; 15: 290301.
  • 8
    Kriz W, LeHir M. Pathways to nephron loss starting from glomerular diseases—insights from animal models. Kidney Int 2005; 67: 404419.
  • 9
    Fogo AB. Mechanisms of progression of chronic kidney disease. Pediatr Nephrol 2007; 22: 20112022.
  • 10
    Taal MW, Chertow GM, Rennke HG, et al. Mechanisms underlying renoprotection during renin-angiotensin system blockade. Am J Physiol Renal Physiol 2001; 280: F343355.
  • 11
    Schiller B, Moran J. Focal glomerulosclerosis in the remnant kidney model—an inflammatory disease mediated by cytokines. Nephrol Dial Transplant 1997; 12: 430437.
  • 12
    Taal MW, Zandi-Nejad K, Weening B, et al. Proinflammatory gene expression and macrophage recruitment in the rat remnant kidney. Kidney Int 2000; 58: 16641676.
  • 13
    Romero F, Rodriguez-Iturbe B, Parra G, et al. Mycophenolate mofetil prevents the progressive renal failure induced by 5/6 renal ablation in rats. Kidney Int 1999; 55: 945955.
  • 14
    T¨ogel F, Yang Y, Zhang P, et al. Bioluminescence imaging to monitor the in vivo distribution of administered mesenchymal stem cells in acute kidney injury. Am J Physiol Renal Physiol 2008; 295: F315F321.
  • 15
    Humphreys BD, Duffield JS, Bonventre JV. Renal stem cells in recovery from acute kidney injury. Minerva Urol Nefrol 2006; 58: 329337.
  • 16
    Humphreys BD, Bonventre JV. Mesenchymal stem cells in acute kidney injury. Annu Rev Med 2008; 59: 311325.
  • 17
    Duffield JS, Bonventre JV. Kidney tubular epithelium is restored without replacement with bone marrow-derived cells during repair after ischemic injury. Kidney Int 2005; 68: 19561961.
  • 18
    Semedo P, Wang PM, Andreucci TH, et al. Mesenchymal stem cells ameliorate tissue damages triggered by renal ischemia and reperfusion injury. Transplant Proc 2007; 39: 421423.
  • 19
    Semedo P, Palasio CG, Oliveira CD, et al. Early modulation of inflammation by mesenchymal stem cell after acute kidney injury. Int Immunopharmacol 2009; 9: 677682.
  • 20
    T¨ogel F, Weiss K, Yang Y, et al. Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury. Am J Physiol Renal Physiol 2007; 292: F1626F1635.
  • 21
    Lin WR, Brittan M, Alison MR. The role of bone marrow-derived cells in fibrosis. Cells Tissues Organs 2008; 188: 178188.
  • 22
    Perez-Ruiz L, Ros-Lopez S, Cardus A, et al. A forgotten method to induce experimental chronic renal failure in the rat by ligation of the renal parenchyma. Nephron Exp Nephrol 2006; 103: e126e130.
  • 23
    Amann K, Irzyniec T, Mall G. The effect of enalapril on glomerular growth and glomerular lesions after subtotal nephrectomy in the rat: a stereological analysis. J Hypertens 1993; 11: 969975.
  • 24
    Fleck C, Appenroth D, Jonas P, et al. Suitability of 5/6 nephrectomy (5/6NX) for the induction of interstitial renal fibrosis in rats—influence of sex, strain, and surgical procedure. Exp Toxicol Pathol 2006; 57: 195205.
  • 25
    Imgrund M, Grone E, Grone HJ, et al. Re-expression of the developmental gene Pax-2 during experimental acute tubular necrosis in mice 1. Kidney Int 1999; 56: 14231431.
  • 26
    Villanueva S, Cespedes C, Vio CP. Ischemic acute renal failure induces the expression of a wide range of nephrogenic proteins. Am J Physiol Regul Integr Comp Physiol 2006; 290: R861R870.
  • 27
    Luria EA, Panasyuk AF, Friedenstein AY. Fibroblast colony formation from monolayer cultures of blood cells. Transfusion 1971; 11: 345349.
  • 28
    Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol 2008; 8: 726736.
  • 29
    Torrente Y, Polli E. Mesenchymal stem cell transplantation for neurodegenerative diseases. Cell Transplant 2008; 17: 11031113.
  • 30
    Ohnishi S, Ohgushi H, Kitamura S, et al. Mesenchymal stem cells for the treatment of heart failure. Int J Hematol 2007; 86: 1721.
  • 31
    Popp FC, Piso P, Schlitt HJ, et al. Therapeutic potential of bone marrow stem cells for liver diseases. Curr Stem Cell Res Ther 2006; 1: 411418.
  • 32
    Hofstetter CP, Schwarz EJ, Hess D, et al. Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proc Natl Acad Sci U S A 2002; 99: 21992204.
  • 33
    Weiss DJ, Kolls JK, Ortiz LA, et al. Stem cells and cell therapies in lung biology and lung diseases. Proc Am Thorac Soc 2008; 5: 637667.
  • 34
    Caldas HC, Fernandes IM, Gerbi F, et al. Effect of whole bone marrow cell infusion in the progression of experimental chronic renal failure. Transplant Proc 2008; 40: 853855.
  • 35
    Choi S, Park M, Kim J, et al. The role of mesenchymal stem cells in the functional improvement of the chronic renal failure. Stem Cells Dev 2009; 18: 521529.
  • 36
    Asawa S, Saito T, Satoh A, et al. Participation of bone marrow cells in biliary fibrosis after bile duct ligation. J Gastroenterol Hepatol 2007; 22: 20012008.
  • 37
    Dunsmore SE, Shapiro SD. The bone marrow leaves its scar: new concepts in pulmonary fibrosis. J Clin Invest 2004; 113: 180182.
  • 38
    Lin SL, Kisseleva T, Brenner DA, et al. Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney. Am J Pathol 2008; 173: 16171627.
  • 39
    Haniffa MA, Collin MP, Buckley CD, et al. Mesenchymal stem cells: the fibroblasts' new clothes? Haematologica 2009; 94: 258263.
  • 40
    Darby IA, Hewitson TD. Fibroblast differentiation in wound healing and fibrosis. Int Rev Cytol 2007; 257: 143179.
  • 41
    Desmouliere A, Chaponnier C, Gabbiani G. Tissue repair, contraction, and the myofibroblast. Wound Repair Regen 2005; 13: 712.
  • 42
    Alexandre CS, Volpini RA, Shimizu MH, et al. Lineage-negative bone marrow cells protect against chronic renal failure. Stem Cells 2009; 27: 682692.
  • 43
    Fujihara CK, Malheiros DM, Zatz R, et al. Mycophenolate mofetil attenuates renal injury in the rat remnant kidney. Kidney Int 1998; 54: 15101519.
  • 44
    Noronha IL, Fujihara CK, Zatz R. The inflammatory component in progressive renal disease–are interventions possible? Nephrol Dial Transplant 2002; 17: 363368.
  • 45
    Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009; 119: 14201428.
  • 46
    Strutz FM. EMT and proteinuria as progression factors. Kidney Int 2009; 75: 475481.
  • 47
    Higgins DF, Kimura K, Bernhardt WM, et al. Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. J Clin Invest 2007; 117: 38103820.
  • 48
    Inumaru J, Nagano O, Takahashi E, et al. Molecular mechanisms regulating dissociation of cell-cell junction of epithelial cells by oxidative stress. Genes Cells 2009 [Epub ahead of print].
  • 49
    Duffield JS, Park KM, Hsiao LL, et al. Restoration of tubular epithelial cells during repair of the postischemic kidney occurs independently of bone marrow-derived stem cells. J Clin Invest 2005; 115: 17431755.
  • 50
    Grimm PC, Nickerson P, Jeffery J, et al. Neointimal and tubulointerstitial infiltration by recipient mesenchymal cells in chronic renal-allograft rejection. N Engl J Med 2001; 345: 9397.
  • 51
    Le Blanc K, Ringden O. Immunomodulation by mesenchymal stem cells and clinical experience. J Intern Med 2007; 262: 509525.
  • 52
    Di Nicola M, Carlo-Stella C, Magni M, et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002; 99: 38383843.
  • 53
    Li L, Zhang Y, Li Y, et al. Mesenchymal stem cell transplantation attenuates cardiac fibrosis associated with isoproterenol-induced global heart failure. Transpl Int 2008; 21: 11811189.
  • 54
    Ninichuk V, Gross O, Segerer S, et al. Multipotent mesenchymal stem cells reduce interstitial fibrosis but do not delay progression of chronic kidney disease in collagen4A3-deficient mice. Kidney Int 2006; 70: 121129.
  • 55
    Dworkin LD, Gong R, Tolbert E, et al. Hepatocyte growth factor ameliorates progression of interstitial fibrosis in rats with established renal injury. Kidney Int 2004; 65: 409419.
  • 56
    Gao X, Mae H, Ayabe N, et al. Hepatocyte growth factor gene therapy retards the progression of chronic obstructive nephropathy. Kidney Int 2002; 62: 12381248.
  • 57
    Yang J, Liu Y. Delayed administration of hepatocyte growth factor reduces renal fibrosis in obstructive nephropathy. Am J Physiol Renal Physiol 2003; 284: F349F357.
  • 58
    Kagawa T, Takemura G, Kosai K, et al. Hepatocyte growth factor gene therapy slows down the progression of diabetic nephropathy in db/db mice. Nephron Physiol 2006; 102:p 92p102.
  • 59
    Cruzado JM, Lloberas N, Torras J, et al. Regression of advanced diabetic nephropathy by hepatocyte growth factor gene therapy in rats. Diabetes 2004; 53: 11191127.
  • 60
    Camara NO, Soares MP. Heme oxygenase-1 (HO-1), a protective gene that prevents chronic graft dysfunction. Free Radic Biol Med 2005; 38: 426435.
  • 61
    Jarmi T, Agarwal A. Heme oxygenase and renal disease. Curr Hypertens Rep 2009; 11: 5662.
  • 62
    Takahashi T, Shimizu H, Morimatsu H, et al. Heme oxygenase-1 is an essential cytoprotective component in oxidative tissue injury induced by hemorrhagic shock. J Clin Biochem Nutr 2009; 44: 2840.